GlassScriptPhysician profile
Imran Sikander Farooq
NPI 1093942393
$6,860.10
in general payments reported to CMS, 2019-2025
28 companies · $873 in 2025
The $873 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $2,120 · 2021: $1,130 · 2022: $270 · 2023: $962 · 2024: $1,190 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,024.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,134.25 | 2019-2025 | Diamondback Coronary |
| Philips North America LLC | $990.87 | 2020-2023 | |
| Kestra Medical Technology Services, INC. | $575.39 | 2023-2025 | Assure Wcd |
| Penumbra, INC. | $527.50 | 2023-2025 | Indigo System, Penumbra System, Smart Coil |
| Silk Road Medical, INC. | $522.16 | 2021 | |
| Abiomed | $480.20 | 2023-2025 | Impella |
| Medtronic, INC. | $474.72 | 2021-2025 | Symplicity G3, Resolute Onyx |
| Inari Medical, INC. | $437.72 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $274.26 | 2025 | |
| Cook Medical LLC | $190.12 | 2019-2023 | Cook Celect |
| Boston Scientific Corporation | $184.67 | 2020-2024 | Ekosonic, Ranger |
| Endologix LLC | $132.18 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $129.05 | 2024-2025 | |
| Cordis US Corp. | $113.32 | 2023 | Mynx Control, Mynxgrip |
| Amgen INC. | $109.96 | 2022-2025 | Repatha |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $97.63 | 2021 | |
| Livanova USA, INC. | $91.77 | 2019-2021 | |
| Cardiovascular Systems INC. | $86.65 | 2019-2023 | Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.84 | 2023-2025 | Lifevest |
| Medtronic USA, INC. | $57.30 | 2020 | |
| Merck Sharp & Dohme LLC | $38.17 | 2022-2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $29.37 | 2024 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $28.36 | 2022-2024 | Farxiga |
| Heartflow, INC. | $23.48 | 2025 | |
| Hikma Pharmaceuticals USA | $20.64 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.59 | 2022 | |
| Novo Nordisk INC | $16.70 | 2024 | Ozempic |
| Cardiva Medical, INC. | $14.23 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.